Close Menu

NEW YORK (GenomeWeb) —Institute for Systems Biology spinout Arivale plans to provide customers with personalized health recommendations based on a variety of molecular and lifestyle datasets, including their genome sequence.

The company, co-founded in early 2014 by ISB President Lee Hood, CEO Clayton Lewis, and ISB Associate Director Nathan Price, said today that it raised $36 million in a Series B funding round that was led by venture firms Arch Venture Partners and Polaris Partners. Maveron, which led Arivale's $3 million Series A round, also participated in the latest round.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.